Adverse events profile of novel agents targeting immune checkpoints beyond PD-1/PD-L1 and CTLA-4 in solid tumors: A meta-analysis.

作者
Yu Fujiwara,Yui Okamura,Mrinalini Ramesh,Yasmin Fakhari-Tehrani,Toshiaki Takahashi,Ross D. McCauley,Sarbajit Mukherjee
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:43 (16_suppl): 2642-2642
标识
DOI:10.1200/jco.2025.43.16_suppl.2642
摘要

2642 Background: PD-1, PD-L1, and CTLA-4 blockade are standard therapies in multiple solid tumors, and novel agents targeting alternative co-stimulatory and co-inhibitory immune checkpoints are under development. Immune checkpoint inhibitors are well known to cause immune-related adverse events (irAEs) and multiple studies reported the accurate incidence of irAEs from PD-1, PD-L1, and CTLA-4 blockade. With the increasing investigation and anticipated approval of novel immunotherapy agents, understanding their toxicity profiles is critical. Methods: We systematically searched PubMed/MEDLINE, EMBASE, and Web of Science for clinical trials published up to December 1st, 2024. Studies evaluating the safety of agents targeting co-inhibitory checkpoints (B7-H3, CD47, TIGIT, LAG-3, and TIM-3) or co-stimulatory checkpoints (OX40, 4-1BB, CD27, ICOS, GITR, CD70, and CD40) in solid tumors were included. Incidence rates of grade 1-5 (G1-5) and grade 3-5 (G3-5) treatment-related adverse events (trAEs) and irAEs were extracted. Toxicity data were derived from phase 2 and 3 trials, as well as phase 1/2 trials with safety information reported at the recommended phase 2 dose. Random-effects meta-analysis was used to pool odds ratios (ORs) from two-arm studies evaluating the addition of LAG-3 or TIGIT blockade to control-arm therapy, and proportional meta-analysis was conducted to analyze AE incidence across immunotherapy subtypes. Results: A systematic review identified 27 clinical trials with 40 cohorts comprising 3,946 patients and evaluating 10 immune checkpoints (B7-H3, LAG-3, TIGIT, CD47, OX40, CD137. TIM-3, CD40, CD27, CD40, ICOS). Meta-analyses showed that the addition of LAG-3 blockade to either PD-1 blockade-based therapy or placebo was associated with increased G3-5 trAEs (OR 1.79, 95% confidence interval [CI]: 1.26–2.54, p = 0.001), G3-5 adrenal insufficiency (OR 8.43, 95% CI: 1.04 - 68.37, p = 0.046), G1-5 adrenal insufficiency (OR 4.81, 95% CI: 1.81-12.78, p = 0.002) and arthralgia (OR 2.07, 95% CI: 1.29-3.30, p = 0.002). The addition of TIGIT blockade to PD-L1 blockade-based therapy was associated with increased G1-5 rash (OR 2.32, 95% CI: 1.01–5.34, p = 0.048) (other outcomes will be shown). Proportional meta-analysis revealed varying irAE patterns across agents: G5 trAEs (0.9-2.9%), G3-5 pneumonitis (0.5-5.5%, highest in TIM-3 blockade), G3-5 colitis (0.2-5.4%, highest in LAG-3 blockade), G3-5 hepatitis (1.5-5.5%, highest in TIM-3 blockade), G3-5 rash (0.8%-18.4%, highest in CD40 agonists), G3-5 adrenal insufficiency (1.7-8.4%, highest in TIGIT blockade) (details of all outcomes will be presented). Conclusions: This study highlights the distinct toxicity profiles of novel immunotherapy agents, providing essential safety data to support clinicians as these therapies move toward anticipated clinical approval.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
英俊的铭的应助被一点漾洋采纳,获得50
1秒前
冷艳的寒天的应助被jinrui采纳,获得10
1秒前
H欢完成签到,获得积分10
1秒前
稳稳完成签到,获得积分10
1秒前
Lucycomplex完成签到,获得积分10
1秒前
qi发布了新的文献求助10
2秒前
2秒前
CAOHOU的应助被qsyslh采纳,获得10
3秒前
蒲公英发布了新的文献求助10
4秒前
dery完成签到 ,获得积分10
4秒前
凉介完成签到,获得积分10
5秒前
CocoGabrielle发布了新的文献求助10
5秒前
5秒前
5秒前
6秒前
科研通AI65的应助被香香香采纳,获得10
6秒前
6秒前
6秒前
吃不饱发布了新的文献求助10
7秒前
7秒前
7秒前
奋斗盼海发布了新的文献求助10
7秒前
Yianyan完成签到 ,获得积分10
7秒前
fantasy的应助被大胆的从云采纳,获得10
7秒前
9秒前
小马发布了新的文献求助10
9秒前
王小丫发布了新的文献求助10
10秒前
郑晓完成签到 ,获得积分10
10秒前
呼呼完成签到,获得积分10
11秒前
小雨发布了新的文献求助10
11秒前
11秒前
田様的应助被小香蕉采纳,获得10
11秒前
11秒前
搜集达人的应助被随机昵称采纳,获得10
12秒前
liuke发布了新的文献求助10
12秒前
12秒前
12秒前
vv完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952